Fox Host Debunks Trump's 600% Drug Price Cut Claim
A Fox News anchor delivered a brutal math lesson on air, highlighting the impossibility of Trump's claim about slashing prescription drug prices by 600%. See the reality vs. perception clash unfold.
Category : Search result: pharmaceutical development
Edmonton housing fees rise fastest in Canada but stay low
A new study reveals development charges in Edmonton have soared 628% since 2010, the highest rate among major cities. Despite the spike, fees per unit remain the lowest, aiding affordability. Explore the details and impacts.
Health Canada Approves Drug for Rare Disease
Health Canada has granted approval for a new pharmaceutical treatment targeting a rare disease, offering hope for patients. Learn about the regulatory decision and its impact.
Pfizer 2026 profit forecast below expectations
Pfizer projects 2026 profits below Wall Street estimates due to a steep drop in COVID product sales and loss of exclusivity for key drugs. Get the full business analysis.
Edmonton council approves condo infill after developer pivot
Edmonton city council approved a rezoning for six condos in Crestwood after the developer changed plans from an 11-unit apartment. The decision followed intense public feedback and a lengthy hearing.
Tribunal clears way for major Cambridge condo project
A tribunal decision has cleared the final hurdle for a major three-tower condo development at the site of the former Preston Springs Hotel in Cambridge, paving the way for significant urban transformation.
Regina Council Opens Proposals for 'The Yards' Development
Regina city council has approved opening applications for proposals to develop 'The Yards' railyard site, marking a major step in urban revitalization. Learn about the next phase for this key project.
Vancouver eyes changes to make housing development viable
Vancouver planning staff propose reducing developer fees and easing affordability rules to keep projects moving. The trade-offs include less funding for public art and delayed infrastructure.
China's Biopharma Surge Challenges Global Drug Leaders
China's biopharma industry is accelerating, fueled by record investment and streamlined supply chains. With faster development times and massive deals like AstraZeneca's $5.2B pact, the global drug innovation race is heating up. Discover the shift from ou
Eli Lilly cuts price of obesity drug Zepbound
Pharmaceutical giant Eli Lilly has reduced the price of its obesity medication Zepbound to improve patient access. The move comes amid growing demand for GLP-1 drugs in Canada and globally.
Kelowna land swap saves golf course from industrial use
Kelowna city staff propose trading industrial land to preserve Kelowna Springs Golf Course as 9-hole facility while allowing partial industrial development. Read the details.
Ontario exempts training centres from municipal laws
Ontario government exempts Skills Development Fund recipients from municipal planning laws to accelerate workforce training. Minister David Piccini announces new policy.
Boehringer Ingelheim Names New Board Member for IT
Boehringer Ingelheim announces Harsha Deshmukh's appointment to Board of Managing Directors for IT and Global Business Services effective February 2026.
Grey Bruce drug disposal nets meds for hockey tickets
Grey Bruce residents exchanged unused pharmaceuticals for Barrie Colts hockey tickets in a successful medication safety initiative. Learn how this program helps combat opioid misuse and environmental contamination.
Dipharma's Novel Method Detects Nitrosamine Risks
Dipharma publishes a peer-reviewed study unveiling a novel method to detect and characterize nitrosamine impurities in Active Pharmaceutical Ingredients, enhancing drug safety and regulatory compliance.
Ottawa plans housing in People's Park, Old Ottawa East
Ottawa City Hall considers building housing in Old Ottawa East's People's Park, sparking community discussion about urban development and green space preservation.
Novo Nordisk Alzheimer's Drug Trials Fail
Danish pharmaceutical giant Novo Nordisk faces major setback as Alzheimer's drug trials fail. Learn how this impacts the weight-loss leader's expansion plans.
India probes cough syrup deaths amid safety concerns
Indian officials are investigating whether safety failures led to children dying from contaminated cough syrup. Get the latest details on this developing health crisis.
Eli Lilly Reaches $1 Trillion Valuation Milestone
Eli Lilly becomes the first pharmaceutical company to achieve a US$1 trillion market valuation, driven by unprecedented demand for its weight-loss treatments. Discover how this milestone reshapes the industry.
Denmark compensates for Novo Nordisk vision loss
Danish authorities provide compensation to patients experiencing vision loss linked to Novo Nordisk medications. Learn about the pharmaceutical safety developments affecting Canadian consumers.
Teva Launches Global Innovation Platform for Pharma Breakthroughs
Teva Pharmaceutical launches Rise, a global open innovation platform connecting startups with pharma challenges in AI, digital health and smart manufacturing to accelerate patient impact.
Journal sued over controversial antidepressant drug trial
A medical journal faces legal action after publishing a study promoting antidepressant use for youth depression treatment. The infamous drug trial returns to spotlight amid growing concerns.
Fake Viagra Sold at Toronto Store: Health Canada
Health Canada warns about counterfeit Viagra discovered at a Toronto convenience store. Learn how to identify fake medications and protect your health.
How to Safely Dispose of Expired Medications
Learn the correct methods for disposing expired or unused medications in Canada. Protect your family and environment with proper drug disposal practices.
Novo Nordisk rolls out $349 Wegovy cash price early
Novo Nordisk introduces $349 cash price for Wegovy weight-loss drug ahead of schedule. Learn how this affects Canadian healthcare access and affordability.
J&J buys Halda Therapeutics for $3.05 billion
Johnson & Johnson expands its oncology portfolio with $3.05 billion acquisition of Halda Therapeutics, strengthening its cancer treatment pipeline. Learn about this major healthcare investment.
Vancouver rezones school land for condo development
Vancouver city council has voted to rezone elementary school land for condominium development. Learn about this controversial decision and its implications for urban planning.
Barbados Launches US$200M Life Sciences Hub
Barbados partners with EarlyHealth Group to build a US$200 million life sciences hub, positioning the island as the Caribbean's premier pharmaceutical and research centre.
B.C. Town Prepares for LNG Growth Spurt Impact
A British Columbia town faces transformative growth as LNG projects spark heated debate over economic benefits versus environmental concerns. Learn about the impacts.
Indigenous Partnerships in Major Canadian Projects
Canada's latest major projects list demonstrates growing Indigenous participation in resource development while highlighting ongoing regulatory challenges. Learn about the key initiatives.
Page 1 of 4